Evidence Hub

Anti-inflammatory effect of quercetin in a murine model of lipopolysaccharide-induced acute lung injury: A systematic review

Giselly de Oliveira Silva, Elizabeth Fernanda de Oliveira Borba, M. T. dos Santos Correia, T. D. da Silva

Concilium, 2024

Abstract

Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are pulmonary manifestations of a systemic inflammation that causes thousands of deaths every year around the world. However, there are still no specific treatment for this disease. Thus, based on a systematic review, this study aimed to investigate the anti-inflammatory effects of quercetin in a murine lipopolysaccharide-induced acute lung injury model. The investigation was conducted in the PubMed, Science Direct, Web of Science, and Scopus databases via Periódicos Capes. Initially, 49 articles were found that went through screening and five studies were selected. The results showed that quercetin, when administered as a possible treatment for acute lung injury in mice, reduced markers of inflammation, such as MDA and NO levels, MPO activity, the accumulation of neutrophils in the lung, number of leukocytes in bronchoalveolar lavage (BAL), release of inflammatory cytokines TNF-α, IL-1β and IL-6 in BAL, pulmonary edema and infiltration in lung tissues.

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free